|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net Income Loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Stock-based compensation expense | |||||
| Non-cash lease expense | |||||
| Fair value adjustment on common warrants | |||||
| Depreciation | |||||
| Changes in operating assets and liabilities: | |||||
| Other assets | |||||
| Accounts receivable | |||||
| Inventory | |||||
| Prepaid expenses | |||||
| Other current assets | |||||
| Accounts payable | |||||
| Accrued expenses | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Proceeds from the sale of investments | |||||
| Purchase of property and equipment | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from common stock and pre-funded common stock warrants | |||||
| Costs of issuance of common stock upon private placement | |||||
| Proceeds from exercise of common stock warrants | |||||
| Proceeds from exercise of stock options | |||||
| Net cash provided by financing activities | |||||
| Change in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning of period | |||||
| Cash and cash equivalents, end of period | |||||
| Supplemental Disclosure of Cash Flow Information: | |||||
| Cash paid for income taxes | |||||
| Cash paid for interest | |||||
| Supplemental Disclosure of Non-Cash Investing and Financing Activities: | |||||
| Fair value of common stock warrant classified as a liability | |||||
| Right-of-use assets obtained in exchange for lease obligations | |||||
Loading...